Vote Scores
Filings read through

Rohto Pharmaceutical Co., Ltd.: how funds voted at the meeting of 24 Jun 2026

Meeting
Season
year to 30 June 2026
Filers reporting
61
Ballot items
13

61 filers on Form N-PX reported votes at the Rohto Pharmaceutical Co., Ltd. meeting of 24 Jun 2026. The records fall into 13 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    14 nominees. 99.2% of the reported votes are for. 3 filers withheld from or voted against at least one nominee.

    1,218 vote records from 60 filers. 0 of the 60 filers that marked the item voted against management.

    • Positions of 24 fund families
    • For 24
  2. Item 2: Director elections (nominees put forward by security holders)

    1 nominee. 2.4% of the reported votes are for. 53 filers withheld from or voted against at least one nominee.

    83 vote records from 55 filers. 2 of the 55 filers that marked the item voted against management.

    • Positions of 22 fund families
    • Against 22
  3. Item 3: Advisory vote on executive pay (say-on-pay)

    1 vote record from 1 filer. 1 of the 1 filer that marked the item voted against management.

  4. Item 4: OTHER: management items

    The company's items in this category are shown together, because filers word and number them differently.

    4 vote records from 4 filers. No filer marked the item for or against management. 4 filers gave no management mark.

    • Positions of 2 fund families
    • Split or no vote 2
  5. Item 5: Amend Articles to Add Provision Concerning Management with Cost of Capital and Share Price Considered

    87 vote records from 60 filers. 8 of the 60 filers that marked the item voted against management.

    • Positions of 24 fund families
    • For 4
    • Against 20
    • Against management 4
  6. Item 6: Amend Articles to Change Record Date for Annual Shareholder Meetings

    87 vote records from 60 filers. 7 of the 60 filers that marked the item voted against management.

    • Positions of 24 fund families
    • For 2
    • Against 22
    • Against management 2
  7. Item 7: Amend Articles to Establish Strategic Review Committee

    87 vote records from 60 filers. 4 of the 60 filers that marked the item voted against management.

    • Positions of 24 fund families
    • For 1
    • Against 23
    • Against management 1
  8. Item 8: Approve Restricted Stock Plan

    87 vote records from 60 filers. 29 of the 60 filers that marked the item voted against management.

    • Positions of 24 fund families
    • For 12
    • Against 12
    • Against management 12
  9. Item 9: Initiate Share Repurchase Program

    73 vote records from 53 filers. 2 of the 53 filers that marked the item voted against management.

    • Positions of 21 fund families
    • Against 21
  10. Item 10: Amend Articles to Restore Shareholder Authority to Vote on Income Allocation and Share Buybacks

    65 vote records from 48 filers. 41 of the 48 filers that marked the item voted against management.

    • Positions of 18 fund families
    • For 15
    • Against 3
    • Against management 15
  11. Item 11: Amend Articles to Require Majority Outsider Board

    64 vote records from 47 filers. 4 of the 47 filers that marked the item voted against management.

    • Positions of 18 fund families
    • For 1
    • Against 17
    • Against management 1
  12. Item 12: Shareholder Proposal: Amend Articles of Incorporation (the composition of outside directors)

    22 vote records from 13 filers. 2 of the 13 filers that marked the item voted against management.

    • Positions of 7 fund families
    • For 1
    • Against 6
    • Against management 1
  13. Item 13: Shareholder proposals (not separable from the filings)

    • Proposed by a security holder
    • Several categories

    Filers described these proposals in different words that the site could not match, so they are shown together.

    41 vote records from 13 filers. 8 of the 13 filers that marked the item voted against management.

    • Positions of 7 fund families
    • For 5
    • Against 1
    • Split or no vote 1
    • Against management 5

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Rohto Pharmaceutical Co., Ltd., meeting of 24 Jun 2026Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family5. Proposal6. Proposal7. Proposal8. Proposal9. Proposal10. Proposal11. Proposal12. Proposal
American CenturyAgainstAgainstAgainstAgainstAgainstAgainstAgainstNo report
BlackRock and iSharesAgainstAgainstAgainstAgainstNo reportNo reportNo reportAgainst
BNY MellonAgainstAgainstAgainstFor, against managementAgainstFor, against managementAgainstNo report
Charles SchwabFor, against managementAgainstAgainstAgainstAgainstNo reportNo reportAgainst
DimensionalAgainstAgainstAgainstFor, against managementAgainstFor, against managementAgainstNo report
EquitableAgainstAgainstAgainstAgainstAgainstFor, against managementAgainstNo report
FidelityAgainstAgainstAgainstAgainstAgainstFor, against managementAgainstNo report
Franklin TempletonAgainstAgainstAgainstFor, against managementAgainstFor, against managementAgainstNo report
Goldman SachsAgainstFor, against managementAgainstAgainstAgainstFor, against managementAgainstNo report
InvescoAgainstAgainstAgainstFor, against managementAgainstFor, against managementAgainstNo report
Jackson National fundsFor, against managementFor, against managementFor, against managementFor, against managementNo reportNo reportNo reportFor, against management
John Hancock and ManulifeAgainstAgainstAgainstFor, against managementNo reportNo reportNo reportAgainst
Lincoln FinancialAgainstAgainstAgainstFor, against managementAgainstFor, against managementAgainstNo report
MFSAgainstAgainstAgainstAgainstAgainstFor, against managementAgainstNo report
NationwideFor, against managementAgainstAgainstAgainstAgainstNo reportNo reportAgainst
Northern Trust and FlexSharesAgainstAgainstAgainstFor, against managementAgainstFor, against managementAgainstNo report
Nuveen and TIAAAgainstAgainstAgainstAgainstAgainstAgainstAgainstNo report
PIMCOAgainstAgainstAgainstFor, against managementAgainstFor, against managementFor, against managementNo report
SEIFor, against managementAgainstAgainstAgainstAgainstNo reportNo reportAgainst
State Street and SPDRAgainstAgainstAgainstAgainstAgainstFor, against managementAgainstNo report
ThriventAgainstAgainstAgainstFor, against managementAgainstFor, against managementAgainstNo report
TransamericaAgainstAgainstAgainstFor, against managementAgainstFor, against managementAgainstNo report
VanguardAgainstAgainstAgainstAgainstAgainstAgainstAgainstAgainst
WisdomTreeAgainstAgainstAgainstFor, against managementAgainstFor, against managementAgainstNo report

Questions

How many filers reported votes at the Rohto Pharmaceutical Co., Ltd. meeting?
61 Form N-PX filers reported votes at the meeting of 24 Jun 2026. On say-on-pay, 1 of 1 filers that marked the item voted against management (100.0%). The filings show 8 separate proposals from security holders.
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Rohto Pharmaceutical Co., Ltd. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Rohto Pharmaceutical Co., Ltd. with a meeting date within three days of 24 Jun 2026. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .